Enzo Biochem, Inc.
Enzo Biochem, Inc. (ENZB) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · ENZB · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
ENZB insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
7
Sell transactions
0.00
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Radoff Bradley Louis director | Aug 20, 2025 | D-Return | 430,000 | $0.01 | $4.3K | 0 | Form 4 ↗ |
PULLY STEVEN J director | Aug 20, 2025 | D-Return | 239,992 | $0.01 | $2.4K | 0 | Form 4 ↗ |
Eckert Patricia Chief Financial Officer | Aug 20, 2025 | D-Return | 25,000 | — | — | 0 | Form 4 ↗ |
Eckert Patricia Chief Financial Officer | Aug 20, 2025 | D-Return | 28,328 | $0.01 | $283.28 | 0 | Form 4 ↗ |
COUCHMAN JONATHAN director | Aug 20, 2025 | D-Return | 277,237 | $0.01 | $2.8K | 0 | Form 4 ↗ |
Cannon Kara Chief Executive Officer | Aug 20, 2025 | D-Return | 55,400 | — | — | 0 | Form 4 ↗ |
Cannon Kara Chief Executive Officer | Aug 20, 2025 | D-Return | 45,065 | $0.01 | $450.65 | 0 | Form 4 ↗ |
Radoff Bradley Louis director | Jan 16, 2025 | Award | 142,897 | — | — | 4.53M | Form 4 ↗ |
PULLY STEVEN J director | Jan 16, 2025 | Award | 142,897 | — | — | 240.0K | Form 4 ↗ |
COUCHMAN JONATHAN director | Jan 16, 2025 | Award | 142,897 | — | — | 142.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Enzo Biochem, Inc. (ENZB) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold ENZB stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
ENZB ownershipEnzo Biochem, Inc. (ENZB) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.